\
&
Contact us
\
&
Contact us
Starts in 3 days from now
Locationonline
ProgrammesOn 3 June 2025, the European Innovation Council and SMEs Executive Agency (EISMEA) is organising an informative webinar about the following calls:
The first three calls are open till 15 October 2025, 17:00 Brussels time.
The Horizon Europe Work Programme 2025 - European Innovation Ecosystems (EIE) and the Horizon Europe Work Programme 2025 - Widening participation and strengthening the European Research Area (WIDERA) are adopted.
For any additional information, please check the European Innovation Ecosystems webpage or contact EISMEA-EU-ECOSYSTEMS@ec.europa.eu.
Registration and more information on the Q&A (slido) can be found here .
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Digital Europe AI Continent Defence Space
Digital, Industry & Space Climate, Energy, Mobility EIC EIE
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
